EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
An EC 2.1.1.* (methyltransferase) inhibitor that interferes with the action of catechol O-methyltransferase (EC 2.1.1.6).
|
|
central nervous system drug
A class of drugs producing both physiological and psychological effects through a variety of mechanisms involving the central nervous system.
antidyskinesia agent
Any compound which can be used to treat or alleviate the symptoms of dyskinesia.
antiparkinson drug
A drug used in the treatment of Parkinson's disease.
|
|
(2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide
|
(E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide
|
ChemIDplus
|
Comtess
|
DrugBank
|
Entacapone
|
KEGG COMPOUND
|
N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide
|
Patent
|